Physician profile
Amy A Roy
NPI 1538504428
$556.40
in general payments reported to CMS, 2019-2025
18 companies · $70.52 in 2025
The $70.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.93 · 2020: $12.09 · 2021: $30.62 · 2022: $25.05 · 2023: $216 · 2024: $122 · 2025: $70.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310 · Education: $98.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.39 |
| Education | $98.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $98.32 | 2023 | Da Vinci Surgical System |
| Novo Nordisk INC | $96.99 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Shield Therapeutics INC | $44.62 | 2023-2024 | Accrufer |
| Lilly USA, LLC | $37.28 | 2023-2024 | Jardiance |
| Applied Medical Resources Corporation | $33.11 | 2023 | |
| Meditrina | $27.04 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.82 | 2019-2024 | Jardiance |
| Ethicon US, LLC | $25.05 | 2022 | |
| Coopersurgical, INC. | $24.57 | 2019 | |
| Astellas Pharma US INC | $21.65 | 2025 | Veozah |
| Esperion Therapeutics, INC. | $18.85 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.81 | 2025 | Nuzyra, Xhance |
| Exact Sciences Corporation | $17.58 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.29 | 2024 | Tezspire |
| Glaxosmithkline, LLC. | $13.85 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $12.71 | 2019 | |
| Therapeuticsmd, INC. | $12.09 | 2020 | |
| Pfizer INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.